73519-50-3 Usage
Chemical compound
2-[4-(6-chlorobenzothiazol-2-yl)oxyphenoxy]propanoic acid
Molecular structure
Complex
Composition
Propanoic acid backbone with a phenoxy group
Phenoxy group
Contains a 6-chlorobenzothiazol-2-yl substituent
Type
Synthetic organic molecule
Potential applications
Pharmaceuticals, agrochemicals, materials science
Further research
Needed to determine specific properties and potential uses
Check Digit Verification of cas no
The CAS Registry Mumber 73519-50-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,5,1 and 9 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 73519-50:
(7*7)+(6*3)+(5*5)+(4*1)+(3*9)+(2*5)+(1*0)=133
133 % 10 = 3
So 73519-50-3 is a valid CAS Registry Number.
InChI:InChI=1/C16H12ClNO4S/c1-9(15(19)20)21-11-3-5-12(6-4-11)22-16-18-13-7-2-10(17)8-14(13)23-16/h2-9H,1H3,(H,19,20)
73519-50-3Relevant academic research and scientific papers
II. Synthesis and biological evaluation of some bioisosteres and congeners of the antitumor agent, 2-{4-[(7-chloro-2-quinoxalinyl)oxylphenoxy}propionic acid (XK469)
Hazeldine, Stuart T.,Polin, Lisa,Kushner, Juiwanna,White, Kathryn,Bouregeois, Nicole M.,Crantz, Brianna,Palomino, Eduardo,Corbett, Thomas H.,Horwitz, Jerome P.
, p. 3130 - 3137 (2007/10/03)
XK469 (1) is among the most highly and broadly active antitumor agents to have been evaluated in our laboratories. Subsequent developmental studies led to the entry of (R)-(+) 1 (NSC 698215) into phase 1 clinical trials (NIH UO1-CA62487). The antitumor me
